These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2545591)

  • 21. Insulin and insulinlike activity in extracts of tumors associated with hypoglycemia.
    Abbasi A; Power L
    Diabetes; 1973 Oct; 22(10):762-7. PubMed ID: 4355187
    [No Abstract]   [Full Text] [Related]  

  • 22. [Expression of MCP/CCR2 in patients of hepatocellular carcinoma and liver cirrhosis].
    Fang N; Fan X; Zhang XS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):553-4. PubMed ID: 19912695
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma.
    Merli M; Riggio O; Servi R; Zullo A; De Santis A; Attili AF; Capocaccia L
    Nutrition; 1992; 8(5):321-5. PubMed ID: 1330106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carbohydrate metabolism in liver diseases].
    Mosin VI
    Klin Med (Mosk); 1974 Feb; 52(2):. PubMed ID: 4619410
    [No Abstract]   [Full Text] [Related]  

  • 25. [Causes of hypoglycemia in extrapancreatic tumors].
    Mähr G
    Dtsch Med Wochenschr; 1983 Feb; 108(8):306-7. PubMed ID: 6297869
    [No Abstract]   [Full Text] [Related]  

  • 26. [Abnormal bile acids in liver cirrhosis and liver cancer].
    Tsujii T; Morita T
    Nihon Rinsho; 1984 Jul; 42(7):1604-9. PubMed ID: 6092742
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
    Mehta A; Singal AG
    Gastroenterology; 2015 Sep; 149(3):816-7. PubMed ID: 26231605
    [No Abstract]   [Full Text] [Related]  

  • 28. [Expression of breast cancer resistance protein in liver cirrhosis, hepatocellular carcinoma and peritumoral tissues].
    Wang YM; Huang GS; Hui YP; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):227-9. PubMed ID: 19335991
    [No Abstract]   [Full Text] [Related]  

  • 29. Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia.
    Ishida S; Noda M; Kuzuya N; Kubo F; Yamada S; Yamanaka T; Isozaki O; Hizuka N; Kanazawa Y
    Intern Med; 1995 Dec; 34(12):1201-6. PubMed ID: 8929651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
    Mathonnet M; Descottes B; Valleix D; Labrousse F; Denizot Y
    World J Gastroenterol; 2006 Feb; 12(5):830-1. PubMed ID: 16521208
    [No Abstract]   [Full Text] [Related]  

  • 31. [Liver and hereditary alpha 1-antitrypsin deficiency].
    Feldmann G
    Gastroenterol Clin Biol; 1993; 17(2):83-93. PubMed ID: 8388836
    [No Abstract]   [Full Text] [Related]  

  • 32. Case report: increased insulin sensitivity in tumor hypoglycemia in a diabetic patient: glucose metabolism in tumor hypoglycemia.
    Barzilai N; Cohen P; Bar-Illan R; McIntyre N; Karnieli E
    Am J Med Sci; 1991 Oct; 302(4):229-34. PubMed ID: 1656753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular Carcinoma Surveillance: Moving Forward or Looking in the Rear-View Mirror?
    Braillon A
    Am J Gastroenterol; 2015 Nov; 110(11):1625. PubMed ID: 26618426
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
    Park BC; Huh MH; Seo JH
    J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of glucagon on bile acid after hepatectomy in patients with hepatocellular carcinoma associated with cirrhosis].
    Sudo T; Bessho H; Miyamoto M; Yasuda C; Uchida T; Kawamura M; Kuyama T
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1710-4. PubMed ID: 2177518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretion of glucagon in liver cell carcinoma.
    Ohneda A; Kobayashi T; Nihei J; Sakai T
    Tohoku J Exp Med; 1985 May; 146(1):47-57. PubMed ID: 2992119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The glucoregulatory hormones in cirrhosis of the liver.
    Smith-Laing G
    Z Gastroenterol; 1979 Jul; 17(7):462-8. PubMed ID: 473836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role of survivin in non-alcoholic fatty liver disease.
    Panera N; Raso R; Nobili V; Alisi A
    Liver Int; 2011 Oct; 31(9):1416-7; author reply 1417. PubMed ID: 21745285
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.
    Pazirandeh S; Khettry U; Gordon FD; Resnick RH; Murray JE; Sheth SG
    Dig Dis Sci; 2007 Jan; 52(1):220-7. PubMed ID: 17160481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to Braillon.
    Chang TS; Wu YC; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Nov; 110(11):1625-7. PubMed ID: 26618427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.